Zandu Realty (Delisted) share news and announcements
BSE: 506720
Formerly Zandu Pharmaceutical works
Last traded ₹1,902.05 on 23 May 2018
Delisted on 18 Mar 2019.
Zandu Realty board meetings
99 filed, newest first. Page 2 of 2.
Feb 2013
7 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 06, 2013, inter alia, Shri Abhijit Datta has been appointed as Director and ....
Jan 2013
29 Jan · Board meeting
Inter-alia to consider and approve the Un-Audited Financial results (Provisional) of the Company for the quarter ended December 31, 2012.
Nov 2012
10 Nov · Board meeting
Board of Directors of the Company at its meeting held on Novebmer 09, 2012, inter alia, has appointed Shri. Sandeep Jhunjhunwala as a Director ....9 Nov · Board meeting
Board of Directors of the Company at its meeting held on Novebmer 09, 2012, inter alia, has appointed Shri. Sandeep Jhunjhunwala as a Director and Manager of the Company w.e.f. November 09, 2012.1 Nov · Board meeting
Inter-alia to consider and approve the Un-Audited Financial Results (provisional) of the Company for the quarter ended September 30, 2012.
Jul 2012
31 Jul · Board meeting
Inter-alia to consider and approve the Un-audited Financial Results (provisional) of the Company for the quarter ended June 30, 2012.
May 2012
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 29, 2012, has approved the following : (1) Shri Harsh Vardhan Agrawal and Shri. Mohan Goenka, Joint Managing Directors of the Company have resigned from the directorship of the Company in the said meeting; (2) In accordance with the provisions of section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2011, the Company proposed to pass resolutions u/s 372A of the Companies Act, 1956 for making loan to, and/ or giving any guarantee(s), and/or provide any security(ies) in connection with the loan(s) made by any other person to, or to any other person by, and/or acquire, by way of subscription, purchase or otherwise the securities of the specified bodies corporate in excess of the limit prescribed under the Act. The Company has appointed Mr. A. K. Labh, Practising Company Secretary of M/s. A. K. Labh & Co.,Company Secretaries, as Scrutiniser for conducting the Postal Ballot Voting process.29 May · Board meeting
Board of Directors of the Company at its meeting held on May 29, 2012, inter alia, has appproved the following: 1. Shri. Harsh Vardhan ....
Jan 2012
27 Jan · Board meeting
Inter-alia to consider and approve the un-audited financial results (provisional) of the Company for the quarter ended December 31, 2011.
Nov 2011
15 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2011 has appointed Shri Aditya Poddar as an Additional Director of the Company and the Audit Committee of the Company has been reconstituted as under : (1) Shri Hari Mohan Marda - Chairman; (2) Shri Aditya Poddar; (3) Shri Mohan Goenka. Shri Anand R Mundra, CEO (Commercial) & Company Secretary will act as Secretary to all the above committees.4 Nov · Board meeting
Inter-alia to consider and approve the Un-audited financial Results (Provisional) of the Company for the quarter ended September 30, 2011.
Aug 2011
16 Aug · Board meeting
13 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 12, 2011, inter alia, has transacted the following: 1. Shri Rajesh Bagaria ....1 Aug · Board meeting
Inter-alia to consider and approve the un-audited financial results (provisional) of the Company for the 1st quarter ended June 30, 2011.
May 2011
23 May · Board meeting
Inter-alia to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2011.
Jan 2011
22 Jan · Board meeting
Inter-alia to consider and approve the un-audited financial results (provisional) of the Company for the quarter ended December 31, 2010.
Dec 2010
3 Dec · Board meeting
Shri Abhijit Datta has been appointed as the Chairman of the Board of Directors of the Company in the Board Meeting held on 12th November 2010.
Nov 2010
2 Nov · Board meeting
To consider and take on record Unaudited Financial Results for the second quarter ended September 30, 2010.
Aug 2010
6 Aug · Board meeting
To consider and take on record Unaudited Financial Results for the first quarter ended June 30, 2010.
Jun 2010
8 Jun · Board meeting
In the Board meeting held on May 26, 2010 the Board of Directors : (1) Appointed Shri. Rajesh Bagaria, Shri. Raj Kumar Sureka, Shri. Abhijit Datta, Shri. Amar Bhalotia, Shri. K. K. Khemka and Shri. H. M. Marda as Additional Directors; (2) Accepted the resignation of Shri. R. S. Agarwal and Shri. R. S. Goenka as Director of the Company.8 Jun · Board meeting
In the Board meeting held on May 26, 2010, the Board of Directors, 1. Appointed Shri. Rajesh Bagaria, Shri. Raj Kumar Sureka, Shri. Abhijit ....
May 2010
19 May · Board meeting
To consider and take on record Annual Audited Accounts for the year ended March 31, 2010.
Jan 2010
20 Jan · Board meeting
Meeting on 28 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Dec 2009
3 Dec · Board meeting
Company had informed the Exchange regarding Board Meeting to be held on December 02, 2009 to consider and take on record Annual Audited Accounts for the year ended March 31, 2009 and for the recommendation of dividend on equity shares, if any. The Company has now informed the Exchange that the Meeting of Board of Directors of the Company is adjourned to December 03, 2009.
Nov 2009
24 Nov · Board meeting
To consider and take on record Annual Audited Accounts for the year ended March 31, 2009 and for the recommendation of dividend on equity shares, if any.
Oct 2009
15 Oct · Board meeting
Meeting on 29 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
13 Jul · Board meeting
Meeting on 20 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
19 Jun · Board meeting
Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Board of Directors of Emami Limited and The Zandu Pharmaceutical Works Limited ("Zandu"), on June 19, 2009 approved:- (a) the demerger of the Realty Undertaking of Emami Limited into a separate company viz. Slick Properties Private Limited to be renamed as 'Emami Infrastructure Limited'. (b) the demerger of the FMCG Undertaking of Zandu into Emami Limited. (c) Realty Undertaking of Emami Limited includes its investment in wholly owned subsidiary Emami Realty Limited and its investment in equity shares of Zandu representing the carrying value of investment in the remaining business after the demerger of the Zandu's FMCG Undertaking i.e. Zandu's non-core undertaking. The Zandu's non-core undertaking to be renamed as "Zandu Realty Limited", each of the demergers shall be conditional upon the other". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jun · Board meeting
To inter-alia, consider and approve the Scheme of Arrangement for restructuring and reorganizing the business of the Company with its holding company, Emami Ltd.
Apr 2009
22 Apr · Board meeting
To consider and take on record Unaudited Financial Results for the fourth quarter ended March 31, 2009.
Mar 2009
30 Mar · Board meeting
Zandu Pharmaceutical Works Ltd. has informed the Exchange that Board of Directors of the Company has, in its meeting held on March 30, 2009, discussed various options for restructuring and reorganizing the business of Company with its holding company i.e. Emami Ltd and authorized and empowered the Committee of the Board of Directors of the Company constituted for this purpose, to do the followings: (1) To examine and evaluate restructuring and reorganizing of business being carried on by both the Companies through merger, demerger or any other arrangement; (2) To appoint advocates, legal advisors, valuers, merchant bankers and any other experts for taking their views and opinions in this respect; (3) To frame appropriate scheme and recommend to the Board of Directors of the Company; (4) To do all such acts and deeds which are necessary in this respect.27 Mar · Board meeting
Inter-alia, to discuss and consider various options of restructuring and reorganizing the business of the Company with its holding company, Emami Limited.
Feb 2009
20 Feb · Board meeting
Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Board of Directors in its meeting held on February 20, 2009, interalia has decided, subject to approval of shareholders through Postal Ballot :- (1) To Shift the Registered Office of the Company from the State of Maharashtra to the State of West Bengal; (2) To Invest in any securities, making any loan(s), giving any guarantee(s), and/or providing any security(ies) in excess of limit prescribed under Section 372A of the Companies Act, 1956.19 Feb · Board meeting
To consider interalia the following: (1) Shifting of Registered Office of the Company from the State of Maharashtra to the State of West Bengal; (2) Investing in any securities, making any loan(s), giving any guarantee(s), and/or providing any security(ies) in excess of limit prescribed under Section 372A of the Companies Act, 1956.
Jan 2009
16 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
22 Oct · Board meeting
Meeting on 31 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Jul 2008
8 Jul · Board meeting
Meeting of the Directors of the Company scheduled to be held on July 15, 2008 has been rescheduled to July 18, 2008, to consider and take on record Unaudited Financial Results for the first quarter ended June 30, 2008.4 Jul · Board meeting
Meeting on 15 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Jun 2008
6 Jun · Board meeting
Zandu Pharmaceutical Works Ltd. had informed the Exchange regarding the Board of Directors meeting to be held on June 06, 2008 for considering, among other matters, the proposal for issue of equity shares / warrants / other convertible instruments to promoters, their relatives, associates, other investors on preferential basis, subject to approval of members in the general meeting. The Company has now informed the Exchange that "Board of Directors in its meeting held on 6th June 2008, discussed and dropped the proposal".5 Jun · Board meeting
For considering, among other matters, the proposal for issue of equity shares / warrants / other convertible instruments to promoters, their relatives, associates, other investors on preferential basis, subject to approval of members in the general meeting.
May 2008
28 May · Board meeting
To consider and take on record Annual Audited Accounts for the year ended March 31, 2008 and for the recommendation of final dividend on equity shares, if any.
Jan 2008
9 Jan · Board meeting
To consider and take on record Unaudited Financial Results for the third quarter ended December 31, 2007, and for the recommendation of interim dividend on equity shares, if any. The record date for the same will be January 28, 2008.
Oct 2007
12 Oct · Board meeting
Meeting on 20 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Aug 2007
20 Aug · Board meeting
To consider and take on record Annual Audited Accounts for the year ended March 31, 2007 and for the recommendation of final dividend on equity shares, if any.
Jul 2007
12 Jul · Board meeting
Meeting on 21 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
12 Apr · Board meeting
Meeting on 21 Apr 2007: “Unaudited Financial Results for the Qtr ended March 31, 2007”
Mar 2007
2 Mar · Board meeting
For the recommendation of interim dividend on equity shares, if any. If interim dividend is recommended, the record date for the same will be kept on March 17, 2007.
Feb 2007
15 Feb · Board meeting
For the recommendation of interim dividend on equity shares, if any. If interim dividend is recommended, the record date for the same will be kept on March 02,2007.
Jan 2007
4 Jan · Board meeting
To consider and take on record Unaudited Financial Results (Provisional) for the third quarter ended 31st December, 2006.